Hey, all, welcome back to the real-life pharmacology podcast. I'm your host, pharmacist Eric Christensen,

and I thank you so much for listening today. If you enjoy the podcast today, definitely go pick up your

free resource. It's the top 200 drugs. It's a study guide I put together on highly testable

clinical pearls, as well as things you're going to see in

real life as well with the top 200 drugs there.

Over a 30 page PDF, absolutely no cost to you.

Just you'll get on our email list.

We've got new podcast episodes and things coming out. You'll get updates with that.

So again, real-life pharmacology.com. Check out that free PDF for subscribing.

All right. So let's get into the drug today. We're going to cover Ziprazadone, which the brand name of

that medication is Giodon.

And this is classified as an antipsychotic.

Specifically, it is a second generation antipsychotic.

With virtually any antipsychotic, the primary uses you're going to see are schizophrenia,

you know, delusional behavior, hallucinations, bipolar disorder with mania, things like that.

Occasionally, in my practice, I have seen it used off-label for dementia-related psychosis.

Of course, we certainly need to remember that there is a boxed warning for increased risk of death

with the use of antipsychotics for that diagnosis, however.

So important to keep that in mind.

Mechanistically, I have covered some antipsychotics in the past.

Primarily, we're looking at the blockade of dopamine receptors.

It may have some antihistamine type effects,

...